NanoEcho AB (publ)
The answer first
Does NanoEcho beat the market?
No, NanoEcho has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 44% of Nordic stocks
- Quality75
- Value70
- Trend1
No. 74 of 195 in healthcare
Max for seven days
Follow NanoEcho with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 October 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about NanoEcho
Your first answer is free, no account needed.
Do you own NanoEcho, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with NanoEcho and a few more. Free, no card.
Super Stock+49.0%In short
- NanoEcho has fallen 84.1% over the past year, including dividends.
- Overall, NanoEcho ranks better than 44% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 98.2%. The price is 98.2% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 44% of Nordic stocks.
No. 74 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 69 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.32
- Asset turnoverSales divided by everything the company owns0.04
- Return on equityProfit divided by equity−118.5%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
High Low price: you pay little for what the company earns and owns.
No. 21 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity0.4
- P/SPrice divided by sales9.0
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 191 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−64.1%
- 6 months−70.9%
- 9 months−82.1%
- 12 months−84.1%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About NanoEcho
NanoEcho AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 5 employees.
NanoEcho AB (publ) engages in developing a new diagnostic method to determine the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is headquartered in Lund, Sweden.


See the full analysis of NanoEcho.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card